| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.08 |